Details of the Drug Reposition

General Information of This Drug (ID: DMCDUJY)

Drug Name
Anti-CD20-CAR vector-transduced autologous T cells   DMCDUJY
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
5 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Follicular lymphoma DISVEUR6 2A80 Phase 1/2 [1]
Diffuse large B-cell lymphoma DISSACK3 2A81 Phase 1/2 [1]
B-cell chronic lymphocytic leukaemia DISNHN2M 2A82.00 Phase 1/2 [1]
Acute lymphoblastic leukaemia DIS87TGM 2A85 Phase 1/2 [1]
Haematopoietic/lymphoid cancer DISNCK1H 2B33.5 Phase 1/2 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT01735604) Genetically Engineered Lymphocyte Therapy in Treating Patients With Lymphoma That is Resistant or Refractory to Chemotherapy